Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial

Objective - To explore the relative contributions of baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP) and lipoproteins on the risk of recurrent stroke or first major cardiovascular event (MCVE) and their potential impact on the benefit of statin treatment. - Methods and resu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Amarenco, Pierre (VerfasserIn) , Goldstein, Larry B. (VerfasserIn) , Callahan, Alfred (VerfasserIn) , Sillesen, Henrik (VerfasserIn) , Hennerici, Michael G. (VerfasserIn) , O’Neill, Blair J. (VerfasserIn) , Rudolph, Amy E. (VerfasserIn) , Simunovic, Lisa (VerfasserIn) , Zivin, Justin A. (VerfasserIn) , Welch, K. M. A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2009]
In: Atherosclerosis
Year: 2008, Jahrgang: 204, Heft: 2, Pages: 515-520
ISSN:1879-1484
DOI:10.1016/j.atherosclerosis.2008.09.008
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.atherosclerosis.2008.09.008
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S002191500800631X
Volltext
Verfasserangaben:Pierre Amarenco, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Blair J. O’Neill, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin, K.M.A. Welch, on behalf of the SPARCL investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1751592111
003 DE-627
005 20220819135838.0
007 cr uuu---uuuuu
008 210317r20092008xx |||||o 00| ||eng c
024 7 |a 10.1016/j.atherosclerosis.2008.09.008  |2 doi 
035 |a (DE-627)1751592111 
035 |a (DE-599)KXP1751592111 
035 |a (OCoLC)1341398992 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Amarenco, Pierre  |e VerfasserIn  |0 (DE-588)1155322851  |0 (DE-627)1016735049  |0 (DE-576)50154657X  |4 aut 
245 1 0 |a Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial  |c Pierre Amarenco, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Blair J. O’Neill, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin, K.M.A. Welch, on behalf of the SPARCL investigators 
264 1 |c [2009] 
300 |b Diagramme 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 18 September 2008 
500 |a Gesehen am 17.03.2021 
520 |a Objective - To explore the relative contributions of baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP) and lipoproteins on the risk of recurrent stroke or first major cardiovascular event (MCVE) and their potential impact on the benefit of statin treatment. - Methods and results - The SPARCL trial randomized 4731 patients with recent stroke or transient ischemic attack (TIA) and no known coronary heart disease and LDL-C between 100 and 190mg/dL to either atorvastatin 80mg/d or placebo. Baseline assessment included SBP, DBP and measurements of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), and triglyceride levels. After 4.9 years of follow-up, there were 575 primary end points (fatal and nonfatal stroke), including 491 ischemic strokes, and 740 MCVEs (stroke plus myocardial infarction and vascular death). Cox regression models analysis showed a trend (P>0.05 and P<0.10) for higher SBP but not DBP to be associated with an outcome stroke with only SBP associated with MCVE. Only baseline low HDL-C was associated with an outcome stroke. Baseline HDL-C, triglycerides, and LDL/HDL ratio were each associated with MCVEs. There were no interactions between any of these baseline variables and the effect of treatment on outcome strokes. - Conclusions - In patients with recent stroke or TIA and no coronary heart disease, only lower baseline HDL-C predicted the risk of recurrent stroke with HDL-C, triglycerides, and LDL/HDL ratio associated with MCVE. Atorvastatin treatment was similarly effective regardless of baseline lipoprotein levels. 
534 |c 2008 
650 4 |a HDL-C 
650 4 |a LDL-C 
650 4 |a Statin 
650 4 |a Stroke 
650 4 |a TIA 
700 1 |a Goldstein, Larry B.  |e VerfasserIn  |4 aut 
700 1 |a Callahan, Alfred  |e VerfasserIn  |4 aut 
700 1 |a Sillesen, Henrik  |e VerfasserIn  |4 aut 
700 1 |a Hennerici, Michael G.  |d 1948-  |e VerfasserIn  |0 (DE-588)11587545X  |0 (DE-627)077527704  |0 (DE-576)290126444  |4 aut 
700 1 |a O’Neill, Blair J.  |e VerfasserIn  |4 aut 
700 1 |a Rudolph, Amy E.  |e VerfasserIn  |4 aut 
700 1 |a Simunovic, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Zivin, Justin A.  |e VerfasserIn  |4 aut 
700 1 |a Welch, K. M. A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Atherosclerosis  |d Amsterdam [u.a.] : Elsevier Science, 1970  |g 204(2009), 2, Seite 515-520  |h Online-Ressource  |w (DE-627)306654091  |w (DE-600)1499887-7  |w (DE-576)081984545  |x 1879-1484  |7 nnas  |a Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial 
773 1 8 |g volume:204  |g year:2009  |g number:2  |g pages:515-520  |g extent:6  |a Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial 
856 4 0 |u https://doi.org/10.1016/j.atherosclerosis.2008.09.008  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S002191500800631X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210317 
993 |a Article 
994 |a 2009 
998 |g 11587545X  |a Hennerici, Michael G.  |m 11587545X:Hennerici, Michael G.  |d 60000  |d 62700  |e 60000PH11587545X  |e 62700PH11587545X  |k 0/60000/  |k 1/60000/62700/  |p 5 
999 |a KXP-PPN1751592111  |e 3890007856 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"noteIll":"Diagramme","extent":"6 S."}],"relHost":[{"title":[{"title_sort":"Atherosclerosis","title":"Atherosclerosis"}],"pubHistory":["Nachgewiesen 11.1970 -"],"part":{"pages":"515-520","issue":"2","year":"2009","extent":"6","volume":"204","text":"204(2009), 2, Seite 515-520"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 14.10.2020"],"disp":"Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trialAtherosclerosis","language":["eng"],"recId":"306654091","origin":[{"publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedDisp":"[1970?]-"}],"id":{"issn":["1879-1484"],"zdb":["1499887-7"],"eki":["306654091"]},"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2009","dateIssuedDisp":"[2009]"}],"id":{"eki":["1751592111"],"doi":["10.1016/j.atherosclerosis.2008.09.008"]},"name":{"displayForm":["Pierre Amarenco, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Blair J. O’Neill, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin, K.M.A. Welch, on behalf of the SPARCL investigators"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Available online 18 September 2008","Gesehen am 17.03.2021"],"language":["eng"],"recId":"1751592111","title":[{"title_sort":"Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial","title":"Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial"}],"person":[{"family":"Amarenco","given":"Pierre","roleDisplay":"VerfasserIn","display":"Amarenco, Pierre","role":"aut"},{"given":"Larry B.","family":"Goldstein","role":"aut","display":"Goldstein, Larry B.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Callahan, Alfred","role":"aut","family":"Callahan","given":"Alfred"},{"role":"aut","display":"Sillesen, Henrik","roleDisplay":"VerfasserIn","given":"Henrik","family":"Sillesen"},{"role":"aut","display":"Hennerici, Michael G.","roleDisplay":"VerfasserIn","given":"Michael G.","family":"Hennerici"},{"family":"O’Neill","given":"Blair J.","display":"O’Neill, Blair J.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Amy E.","family":"Rudolph","role":"aut","display":"Rudolph, Amy E.","roleDisplay":"VerfasserIn"},{"given":"Lisa","family":"Simunovic","role":"aut","roleDisplay":"VerfasserIn","display":"Simunovic, Lisa"},{"family":"Zivin","given":"Justin A.","display":"Zivin, Justin A.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Welch, K. M. A.","given":"K. M. A.","family":"Welch"}]} 
SRT |a AMARENCOPIBASELINEBL2009